The Dow Jones Industrial Average is trading up Friday morning with shares of Boeing and Honeywell seeing positive gains for the price-weighted average. Shares of Boeing and Honeywell have contributed ...

Merck KGaA agreed to a deal with RNA biotech Skyhawk Therapeutics that could top out at $2 billion. Roche’s Genentech terminated a cell therapy partnership with Adaptive Biotechnologies, ending what ...

"Prior to the EV-302 clinical trial, the treatment of advanced bladder cancer treatment hadn't significantly changed since ...

Merck & Company Inc. is riding a wave of positive sentiment, signaling a potential near and mid-term breakout. As the current ...

Stamford: SpringWorks Therapeutics, Inc., a healthcare company of Merck, has received marketing authorization from the ...

Treatment for advanced bladder cancer had not significantly changed for 40 years. Now thousands are set to benefit ...

EXCLUSIVE: Patients and doctors are “astonished” and “heartbroken” a proposal to help Australians battling rare cancers ...

Padcev-Keytruda will now join Bristol Myers Squibb’s Opdivo in the list of bladder cancer drugs available on the NHS.